Mitotic kinase Aurora-A is overexpressed in glioma cells, and its expression is reported to be correlated with patient outcome [48]; furthermore, Plk1 activity was found to be elevated in CD133+ glioblastoma multiforme cells [49]. This evidence concerns the gene PLK1 and glioblastoma.